We are thrilled to announce that our journal article, titled “OntoloViz: a GUI for interactive visualization of ranked disease or […]
Author: Kurt Herpel
Drug Indication Expansion: Unlocking Untapped Potential
In the vast ecosystem of the pharmaceutical industry, drug indication expansion plays a pivotal role in maximizing the potential of […]
Advancing Healthcare Through Drug Discovery Services: Unleashing the Power of Innovation
In the realm of healthcare, the journey from a promising drug idea to an effective therapy is not a straightforward […]
What is Drug Discovery? Unveiling the Process, Challenges, and Future
In the intricate world of healthcare, the journey of a drug from a basic idea to a therapy that can […]
Delta4 Identifies a Potential New Therapeutic Option for Focal Segmental Glomerulosclerosis (FSGS) using computational Hyper-C Drug Discovery Platform
Delta4, a digital drug discovery company, identified a potential therapeutic option for Focal Segmental Glomerulosclerosis (FSGS) using their Hyper-C AI […]
Understanding the Drug Discovery Pipeline: From the Lab to the Patient
The world of pharmaceuticals is complex and layered. At the heart of this realm is the drug discovery pipeline, a […]
The Transformative Role of AI in Pharma – An Exploration
What is Artificial Intelligence? Artificial Intelligence (AI) is a field of computer science that aims to mimic human intelligence, enabling […]
Delta4 CEO Kurt Herpel Featured in Insightscare Magazine: A Vision for the Future of Drug Discovery
We are incredibly proud to share that our esteemed CEO, Kurt Herpel, has recently been profiled in Insightscare Magazine. In […]
Delta4 Announces Prof. Doron Lancet To Join Scientific Advisory Board
VIENNA, Austria, March 6th, 2023 — Delta4, a digital drug discovery company focusing on the identification of new indications for […]
4P-Pharma And Delta4 Join Forces To Find And Develop Treatments For A Rare Autoimmune Chronic Liver Disease
Paris (France) and Vienna (Austria), 31st May 2022 – 4P-Pharma, a French clinical-stage biotechnology company, and Delta4, an Austrian digital […]